EP3512529A4 - Arzneimittelverabreichungszusammensetzungen und -verfahren - Google Patents

Arzneimittelverabreichungszusammensetzungen und -verfahren Download PDF

Info

Publication number
EP3512529A4
EP3512529A4 EP16916372.2A EP16916372A EP3512529A4 EP 3512529 A4 EP3512529 A4 EP 3512529A4 EP 16916372 A EP16916372 A EP 16916372A EP 3512529 A4 EP3512529 A4 EP 3512529A4
Authority
EP
European Patent Office
Prior art keywords
methods
drug delivery
delivery compositions
compositions
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16916372.2A
Other languages
English (en)
French (fr)
Other versions
EP3512529A1 (de
Inventor
Ali Razavi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP3512529A1 publication Critical patent/EP3512529A1/de
Publication of EP3512529A4 publication Critical patent/EP3512529A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A61L2300/214—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EP16916372.2A 2016-09-16 2016-09-16 Arzneimittelverabreichungszusammensetzungen und -verfahren Withdrawn EP3512529A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2016/052240 WO2018052443A1 (en) 2016-09-16 2016-09-16 Drug delivery compositions and methods

Publications (2)

Publication Number Publication Date
EP3512529A1 EP3512529A1 (de) 2019-07-24
EP3512529A4 true EP3512529A4 (de) 2020-05-06

Family

ID=61619222

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16916372.2A Withdrawn EP3512529A4 (de) 2016-09-16 2016-09-16 Arzneimittelverabreichungszusammensetzungen und -verfahren

Country Status (2)

Country Link
EP (1) EP3512529A4 (de)
WO (1) WO2018052443A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10980922B2 (en) * 2016-05-03 2021-04-20 Medtronic, Inc. Hemostatic devices and methods of use
US10933174B2 (en) 2016-05-03 2021-03-02 Medtronic, Inc. Hemostatic devices and methods of use
US10765782B2 (en) 2016-05-03 2020-09-08 Medtronic, Inc. Hemostatic devices and methods of use
WO2022178005A1 (en) * 2021-02-17 2022-08-25 Oxion Dental, Llc Stabilized active oxygen-generating antiseptic compositions, irrigation solutions, and articles

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725576A (en) * 1983-12-29 1988-02-16 Research Foundation Of State University Of New York Fungicidal polypeptide compositions containing L-histidine and methods for use therefore
US20110044914A1 (en) * 2008-02-08 2011-02-24 Colgate -Palmolive Company Cleaning compositions and methods
US20110212187A1 (en) * 2008-09-17 2011-09-01 Taminco Antimicrobial composition
US20110229583A1 (en) * 2010-03-17 2011-09-22 David Van Tran Human Medicinal Treatment Typically Using Salt of Peroxymonosulfuric Acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6361551B1 (en) * 1998-12-11 2002-03-26 C. R. Bard, Inc. Collagen hemostatic fibers
US20120074014A1 (en) * 2010-09-27 2012-03-29 Lutran Industries, Inc. Product typically based on salt of peroxymonosulfuric acid and suitable for medicinal usage, and associated product fabrication

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725576A (en) * 1983-12-29 1988-02-16 Research Foundation Of State University Of New York Fungicidal polypeptide compositions containing L-histidine and methods for use therefore
US20110044914A1 (en) * 2008-02-08 2011-02-24 Colgate -Palmolive Company Cleaning compositions and methods
US20110212187A1 (en) * 2008-09-17 2011-09-01 Taminco Antimicrobial composition
US20110229583A1 (en) * 2010-03-17 2011-09-22 David Van Tran Human Medicinal Treatment Typically Using Salt of Peroxymonosulfuric Acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2018052443A1 *

Also Published As

Publication number Publication date
WO2018052443A1 (en) 2018-03-22
EP3512529A1 (de) 2019-07-24

Similar Documents

Publication Publication Date Title
EP3355954A4 (de) Freisetzungsverfahren und zusammensetzungen
EP3558424A4 (de) Arzneimittelverabreichungssysteme und -verfahren
EP3294398A4 (de) System und verfahren zur verabreichung von arzneimitteln
EP3411414A4 (de) Zusammensetzungen und verfahren zur gezielten cytokinfreisetzung
EP3300507A4 (de) Genverabreichungsverfahren und zusammensetzungen
EP3250258A4 (de) Verfahren und systeme zur wirkstofffreisetzung
EP3426348A4 (de) 3-desoxy-derivat und pharmazeutische zusammensetzungen davon
EP3357513A4 (de) Pharmazeutische zusammensetzung und verabreichung davon
EP3265064A4 (de) Arzneimittelabgabevorrichtung
EP3094343A4 (de) Insulinformulierungen mit schneller wirkung und pharmazeutisches verabreichungssystem
EP3310343A4 (de) Implantierbare arzneimittelabgabezusammensetzungen und verfahren zur verwendung davon
EP3378482A4 (de) Formulierung zur verabreichung eines antitumor-arzneimittel
EP3233192A4 (de) Zusammensetzungen und verfahren zur gezielte freisetzung von cytokin
EP3474857A4 (de) Zusammensetzungen und verfahren zur abgabe von therapiemitteln
EP3434285A4 (de) Pharmazeutische zusammensetzungen und verwendung davon
EP3307265A4 (de) Pharmazeutische kombination und verwendungen davon
EP3177286A4 (de) Zusammensetzungen und verfahren zur physiologischen freisetzung von cannabidiol
EP3182970A4 (de) Zusammensetzungen und verfahren für cannabinoidbeschichtungen zur verwendung in der wirkstofffreisetzung
ZA202001044B (en) Drug delivery composition
EP3723750A4 (de) Arzneimittel und zusammensetzungen zur verabreichung in das auge
EP3091983A4 (de) Produkte und pharmazeutische zusammensetzungen
EP3560518A4 (de) Komplex zur verabreichung und stabilisierung von arzneimitteln und verfahren zur herstellung davon
EP3185873A4 (de) Pharmazeutische zusammensetzung und verfahren
EP3773654A4 (de) Pharmazeutische wirkstoffzusammensetzungen und zugehörige verfahren
EP3388085A4 (de) Pharmazeutische zusammensetzung und anwendungen davon

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20190404

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20200402

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 33/04 20060101ALI20200328BHEP

Ipc: A61K 33/40 20060101AFI20200328BHEP

Ipc: A61L 15/46 20060101ALI20200328BHEP

Ipc: A61L 15/18 20060101ALI20200328BHEP

Ipc: A61P 17/02 20060101ALI20200328BHEP

Ipc: A61L 15/26 20060101ALI20200328BHEP

Ipc: A61L 15/32 20060101ALI20200328BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20200819